Lonza | LONN - Gewinn Vor Steuern

Aktienkurs
479.20
Täglich Wechseln
5.20 1.10%
Monatlich
-5.07%
Jährlich
-20.11%
Q2 Prognose
470.40




Gewinn Vor Steuern Veränderung Datum
Akzo Nobel EUR 148M 598M 2026-03
Alcon AG USD 264M 19M 2025-12
Almirall EUR 30.32M 22M 2025-12
AstraZeneca USD 3.91B 1.28B 2026-03
BASF EUR 35M 109M 2025-09
Bayer EUR -1.16B 735M 2025-09
Beiersdorf EUR 408.5M 43.5M 2025-06
Covestro EUR -9M 20M 2025-09
Demant DKK 1.46B 497M 2025-06
Fresenius EUR 601M 122M 2025-12
Fresenius Medical Care EUR 508.46M 105.89M 2025-12
Geberit CHF 115.3M 73M 2024-12
Genmab DKK 55M 427M 2025-12
Givaudan CHF 642M 292M 2024-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
GN Store Nord DKK 450M 332M 2025-12
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Johnson Matthey GBP 201M 68M 2025-06
Merck EUR 1.29B 458.1M 2025-09
Novartis USD 4.64B 445M 2025-12
Philips EUR 275M 62M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Sika AG CHF 738.8M 80.1M 2025-06
Smith & Nephew USD 469M 70M 2025-12
Solvay EUR 51M 44M 2025-09
UCB EUR 789M 427M 2025-06